Global Oncology Access: How Much Do We Really Know. becomes clinically important the moment a team has to turn good intentions into reliable action inside clinical documentation, payer communication, supervision records, and leadership review.
Provider: BehaviorLive — via AVBCC
Take This Course →Including ethics, supervision, and topics like this one. New live CEU every Wednesday.
Join Free →Policymakers and others increasingly refer to ex-US regulatory and reimbursement agencies in domestic conversations. These systems may not be fully understood. Experts in global oncology value and access discuss how ex-US health systems approach oncology drug approval, contracting and reimbursement and what it means for US providers, payers and drug developers and the patients they serve.
| Certification Body | Credits | Type |
|---|---|---|
| BACB | 1 | General |
Dig into the research behind this topic — plain-English summaries written for BCBAs.
280 research articles with practitioner takeaways
231 research articles with practitioner takeaways
225 research articles with practitioner takeaways
All behavior-analytic intervention is individualized. The information on this page is for educational purposes and does not constitute clinical advice. Treatment decisions should be informed by the best available published research, individualized assessment, and obtained with the informed consent of the client or their legal guardian. Behavior analysts are responsible for practicing within the boundaries of their competence and adhering to the BACB Ethics Code for Behavior Analysts.